Telehealth prescribing of GLP-1 medications is legal in most US states when: The prescribing provider is licensed in your state of residence (not just any state) The provider conducts a compliant clinical evaluation asynchronous (form-based) consultations meet this standard in most states The prescription is issued through a certified, Surescripts-registered electronic prescribing system The provider makes an independent clinical judgment not simply rubber-stamping patient requests GLP-1 medications are not controlled substances, which means prescribing rules are less restrictive than for medications like testosterone
Telemetric monitoring in idiopathic intracranial hypertension demonstrates intracranial pressure in a case with sight-threatening disease
In an experimental study conducted by Noyan-Ashraf and colleagues, Liraglutide upregulated the independent expression of cardioprotective genes, including Akt, PPAR-, Nrf-2, and HO-1, while suppressing the expression of GSK3 and activation of caspase-3 in murine hearts [56]
However, the magnitude of effect is considerably smaller than that achieved with pharmaceutical GLP-1 receptor agonists
Garber A, Henry R, Ratner R, et al, for the LEAD-3 (Mono) Study Group